Pharmaceuticals Not Likely To Be A Target Of Republicans In Coming Congress, Hill Watchers Say
This article was originally published in The Pink Sheet Daily
Executive Summary
Some issues - such as drug importation or rebates for Medicare/Medicaid dual eligibles - could surface. GOP could make "surgical strikes" on health reform law, including the Independent Payment Advisory Board, if overall repeal of reform law fails.